Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Endoskopie in Österreich (Stand 2010)
Kardiologie in Österreich (Stand 2006)
Osteologie in Österreich (Stand 2016)
Fachbücher
Patientenliteratur
Gasser R, Klein W, Köppel H Lercanidipine, a new third generation Ca-antagonist in the treatment of hypertension Journal of Clinical and Basic Cardiology 1999; 2 (2): 169-174 PDF Summary Overview
| ||||
Figure/Graphic 1: Lercandipin - systolischer Blutdruck Mean decrease in systolic blood pressure (SBP) after 4 weeks of treatment as seen by Circo in 132 patients (redrawn according to [37]; grey: 24 +/- 2 hours post-dose; black: 4-5 hours post-dose) |
Figure/Graphic 1: Lercandipin - systolischer Blutdruck
Mean decrease in systolic blood pressure (SBP) after 4 weeks of treatment as seen by Circo in 132 patients (redrawn according to [37]; grey: 24 +/- 2 hours post-dose; black: 4-5 hours post-dose) |